Skip to main content

Table 1 Medical resource utilization and prescribed medications in 2008 (United Kingdom)

From: Prescribed therapy for asthma: therapeutic ratios and outcomes

  R = 0% 0% < R < 50% R ≥ 50% p-value
All patients     
Number of patients 6,996 14,903 16,738  
Age, years (mean) 28.9 29.4 29.4 <0.0001
Gender, female (%) 49.6% 53.8% 55.1% <0.0001
Number of GP visits (mean) 5.5 7.7 6.6 <0.0001
Prescribed therapy
Number of respiratory medication prescriptions (mean) 3.6 12.9 6.9 <0.0001
Patients with ≥ 1 prescription of LABA- - 41.1% 44.3% <0.0001
ICS fixed combination (%)     
Number of short-acting beta agonists prescriptions (mean) 3.4 6.7 2.7 <0.0001
Systemic corticosteroids     
Patients with ≥ 1 prescription (%) 6.2% 22.5% 12.7% <0.0001
Number of prescriptions (mean) 0.1 0.5 0.2 <0.0001
Antibiotics (a)     
Patients with ≥ 1 prescription (%) 34.5% 47.9% 41.4% <0.0001
Number of prescriptions (mean) 0.7 1 0.8 <0.0001
Patients with at least 6 prescriptions of respiratory medications in 2008
Number of patients 1,384 11,835 8,391  
Systemic corticosteroids     
Patients with ≥ 1 prescription (%) 8.2% 24.6% 15.5% <0.0001
Number of prescriptions (mean) 0.2 0.5 0.3 <0.0001
Antibiotics (a)     
Patients with ≥ 1 prescription (%) 35% 49.3% 44.8% <0.0001
Number of prescriptions (mean) 0.8 1.1 0.9 <0.0001
  1. (a)Beta-lactams, cephalosporins (first to third generation), macrolides and fluoroquinolones.